Chargement en cours...
Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report
Whether somatostatin analogs for acromegaly improve or worsen a patient's glycemic profile is controversial. A risk of hypoglycemia should be presumed, especially when patients receive insulin therapy, as the package inserts caution. However, a detailed clinical course of such a case has never...
Enregistré dans:
| Publié dans: | J Diabetes Investig |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5754526/ https://ncbi.nlm.nih.gov/pubmed/28390105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12675 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|